The Stem Cell Evidence Alert is out! Check your inbox or see a web version here: https://tinyurl.com/3dc454c3 Sign up FREE at www.stemcellevidence.com/alerts
#BMT #StemCellEvidence

The Stem Cell Evidence Alert is out! Check your inbox or see the web version here https://bit.ly/41Jl1CX Sign up FREE at http://stemcellevidence.com/alerts to receive future editions in your inbox
#BMT #StemCellEvidence

The March #StemCellEvidence Alert is out! If you don't receive it free in your inbox, sign up and see this month's top ten references here: http://www.stemcellevidence.com/alerts
#BMT #leusm #mmsm #lymsm

Our group's impact in 2022 #StemCellEvidence #Transfusion #Evidence

Our group's impact in 2022 #StemCellEvidence #Transfusion #Evidence

T-replete #cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy Our top article this month in the #StemCellEvidence Alert by Claire Horgan et al in @BloodAdvances
stemcellevidence.com/article/366495…
#leusm #BMT

The Stem Cell Evidence Alert is out! Check your inbox or visit http://www.stemcellevidence.com/alerts to see our top ten and sign up FREE
#BMT #StemCellEvidence

From our Evidence Alert this month: Stem cell mobilization yields with daratumumab and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma Chhabra et al in Transplantation and Cellular Therapy http://www.stemcellevidence.com/article/36494017
#BMT #mmsm #StemCellEvidence

Our top article this month is Hermine et al in @JCO_ASCO High-Dose Cytarabine and AutoHSCTin Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial. http://www.stemcellevidence.com/article/36469833 #BMT #StemCellEvidence
#BMT #lymsm #StemCellEvidence

Happy new year from #StemCellEvidence. Our first top ten of the year is out. Check your inbox or got to http://www.stemcellevidence.com/alerts to see our top ten and subscribe to our free monthly alert
#BMT

New from the #StemCellEvidence Alert: Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis – Shimomura et al in Bone Marrow Transplantation
http://www.stemcellevidence.com/alerts/article/36376472
#MDS #BMT

From our evidence alert this month: A phase 2 study of Interleukin-22 and systemic corticosteroids as initial treatment for acute #GVHD of the lower GI tract Ponce et al in Blood Journal
http://www.stemcellevidence.com/alerts/article/36399701
#BMT #StemCellEvidence

Pre-hematopoietic stem cell transplant rituximab for #Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients - Patel et al in Transplantation and Cellular Therapy
http://www.stemcellevidence.com/alerts/article/36334653
#BMT #StemCellEvidence

From the #StemCellEvidence Alert this month: Herrera et al in Lancet Haematology on Brentuximab vedotin plus nivolumab after autologous HSCT for adult patients with high-risk classic Hodgkin lymphoma
http://www.stemcellevidence.com/alerts/article/36403579
#BMT #lymsm

Cryopreserved versus fresh peripheral blood transplant outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the #COVID pandemic - Guo et al in Int J Hematology
http://www.stemcellevidence.com/alerts/article/36378406
#BMT #StemCellEvidence

From our evidence alert this month: Gjaerde et al in Transplantation and Cellular Therapy on Pre-Transplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Non-Relapse Mortality in Allo-HSCT
http://www.stemcellevidence.com/alerts/article/36375798
#BMT #StemCellEvidence

New from the Stem Cell Evidence Alert: Dertschnig et al in Transplantation and Cellular Therapy on Mocravimod, allo-HSCT for malignancy
http://www.stemcellevidence.com/article/36343893
#BMT #GvHD #StemCellEvidence

One of our top ten picks in the #StemCellEvidence Alert this month: Boyiadzis et al in Leukemia journal on Impact of pre-transplant induction and consolidation cycles on #AML allogeneic transplant outcomes: a CIBMTR analysis
http://www.stemcellevidence.com/article/36310182
#BMT #leusm

Our top article this month is Rey-Bua et al in
Cancers
on Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL)
http://stemcellevidence.com/article/36428762
#BMT #lymsm #StemCellEvidence

The #StemCellEvidence Alert is out! Check your inbox or see a web version here https://bit.ly/3YAIsNk. If you don't receive our free alert, sign up at www.stemcellevidence.com/alerts